ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Caffeic acid phenethyl ester alleviated hypouricemia in hyperuricemic mice through inhibiting XOD and up-regulating OAT3

Yong, Tianqiao; Liang, Danling; Chen, Shaodan; Xiao, Chun; Gao, Xiong; Wu, Qingping*; Xie, Yizhen; Huang, Longhua; Hu, Huiping; Li, Xiangmin; Liu, Yuancao; Cai, Manjun广东医学院
PHYTOMEDICINE2022-8DOI: 10.1016/j.phymed.2022.154256
6被引25阅读
引用收藏
分享

摘要

Background: Hyperuricemia is characterized with high serum uric acids (SUAs) and directly causes suffering gout. Caffeic acid phenethyl ester (CAPE) is widely included in dietary plants and especially propolis of honey hives. Hypothesis/Purpose: Since CAPE exerts a property resembling a redox shuttle, the hypothesis is that it may suppress xanthine oxidase (XOD) and alleviate hyperuricemia. The aim is to unveil the hypouricemic effect of CAPE and the underlying mechanisms. Methods: By establishing a hyperuricemic model with potassium oxonate (PO) and hypoxanthine (HX) together, we investigated the hypouricecmic effect of CAPE. On this model, the expressions of key mRNAs and proteins, including glucose transporter 9 (GLUT9) and urate transporter 1 (URAT1), and the activity of XOD were assayed in vivo. Also, the inhibitory effect of CAPE against XOD was assayed in vitro through enzymatic activity tests and by molecular docking. Results: CAPE demonstrated a remarkable hypouricemic effect, which reduced the SUAs of hyperuricemic mice (401 +/- 111 mu mol/l) to 209 +/- 56, 204 +/- 65 and 154 +/- 40 mu mol/l (p < 0.01) at the doses of 15, 30 and 60 mg/kg respectively, depicting efficacies between 48 and 62% and approaching allopurinol's efficacy (52%). Serum parameters, body weights, inner organ coefficients, and H & E staining suggested that CAPE displayed no general toxicity and it alleviated the liver and kidney injuries caused by hyperuricemia. Mechanistically, CAPE decreased XOD activities significantly in vivo, presented an IC50 at 214.57 mu M in vitro and depicted a favorable binding to XOD in molecular simulation, indicating that inhibiting XOD may be an underlying mechanism of CAPE against hyperuricemia. CAPE did decreased GLUT9 protein and down-regulated URAT1 mRNA and protein. In addition, CAPE up-regulated ATP binding cassette subfamily G member 2 (ABCG2) and organic anion transporter 3 (OAT3) mRNA and proteins in comparison with that of the hyperuricemic control. All above, CAPE may alleviate hyperuricmia through inhibiting XOD, decreasing GLUT9 and URAT1 and increasing ABCG2 and OAT3. Conclusion: CAPE presented potent hypouricemic effect in hyperuricemic mice through inhibiting XOD activity and up-regulating OAT3. CAPE may be a promising treatment against hyperuricemia.

学科与关键词

关键词
Caffeic acid phenethyl esterHyperuricemiaXanthine oxidaseOrganic anion transporter 3
相关
加载中…
  • Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase
    Chen, Yanyu; Zhao, Zean; Li, Yongmei; Yang, Yang; Li, Lu; Jiang, Yu; Lin, Cuiting; Cao, Ying; Zhou, Pingzheng; Tian, Yuanxin; Wu, Ting*; Pang, Jianxin*PHYTOMEDICINE, 2021, 80: 153374.被引 46
  • Hypouricemic effect of 2,4-dihydroxybenzoic acid methyl ester in hyperuricemic mice through inhibiting XOD and down-regulating URAT1
    Yong, Tianqiao; Liang, Danling; Xiao, Chun; Huang, Longhua; Chen, Shaodan; Xie, Yizhen; Gao, Xiong; Wu, Qingping*; Hu, Huiping; Li, Xiangmin; Liu, Yuancao; Cai, ManjunBiomedicine and Pharmacotherapy, 2022, 153: 113303.被引 2
  • Eupatilin inhibits xanthine oxidase in vitro and attenuates hyperuricemia and renal injury in vivo
    Xu, Guitao; Wu, Lele; Yang, Hongxuan; Liu, Tianfeng; Tong, Ying; Wan, Jiliang; Han, Bin; Zhou, Lin*; Hu, Xuguang*Food and Chemical Toxicology, 2024, 183: 114307.
查看全部 →

发表信息

论文状态
公开发表
期刊
PHYTOMEDICINE
发表日期
2022-08
卷期
第 103 卷
页码
154256
DOI
10.1016/j.phymed.2022.154256
语言
GERMAN
期刊等级
2区
成果收录
SCIE
资助标注
Key-Area Research and Development Program of Guangdong Province [2018B020206001, 2018B020205001]; National Natural Science Foundation of China [31901696, 81803393]; Science and Technology Program of Guangzhou [202002030225, 201707020022]; Natural Science Foundation of Guangdong Province of China [2022A1515011066, 2021A1515010960]; Guangdong Province Sail Plan [2017YT05S115]; GDAS Project of Science and Technology Development [2020GDASYL-20200103020]

作者

  • Y

    Yong, Tianqiao (第一作者)

  • L

    Liang, Danling

    guangdong med univ

查看全部 12 位作者收起作者
  • C

    Chen, Shaodan

  • X

    Xiao, Chun

  • G

    Gao, Xiong

  • W

    Wu, Qingping (通讯)

  • X

    Xie, Yizhen

  • H

    Huang, Longhua

  • H

    Hu, Huiping

  • L

    Li, Xiangmin

  • L

    Liu, Yuancao

  • C

    Cai, Manjun

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417